Will Analogs of 1,25-Dihydroxyvitamin D3 (Calcitriol) Open a New Era in Cancer Therapy?

Publisher： Karger

E-ISSN： 2296-5262|24|2|128-133

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.24, Iss.2, 2001-05, pp. : 128-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

1,25-Dihydroxyvitamin D3 and cisplatin synergistically induce apoptosis and cell cycle arrest in gastric cancer cells

By            

International Journal of Molecular Medicine, Vol. 33, Iss. 5, 2014-01 ,pp. : 1177-1184

Spandidos Publications

Access to resources Recommend Favorite

Simultaneous Evaluations of 1,25‐Dihydroxyvitamin D3 Receptors in Fresh Layers of Epidermis and Dermis from Normal Rat Skin

By  

THE JOURNAL OF DERMATOLOGY, Vol. 15, Iss. 4, 1988-08 ,pp. : 299-303

John Wiley & Sons Inc

Access to resources Recommend Favorite

1,25‐Dihydroxy‐vitamin D3 regulates NK‐cell cytotoxicity, cytokine secretion, and degranulation in women with recurrent pregnancy losses

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 11, 2015-11 ,pp. : 3188-3199

John Wiley & Sons Inc

Access to resources Recommend Favorite

1,25-Dihydroxyvitamin D3 prevents toluene diisocyanate-induced airway epithelial barrier disruption

By                      

International Journal of Molecular Medicine, Vol. 36, Iss. 1, 2015-01 ,pp. : 263-270

Spandidos Publications

Access to resources Recommend Favorite

1,25-Dihydroxyvitamin D3 Upregulates Functional C-X-C Chemokine Receptor Type 4 Expression in Human Eosinophils

By  

International Archives of Allergy and Immunology, Vol. 158, Iss. 1, 2012-05 ,pp. : 51-57

Karger

Access to resources Recommend Favorite